News
In the latest setback for Pfizer's sickle cell anemia treatments, experimental drug inclacumab failed to meet the main goal ...
The FDA’s announcement of Papzimeos’ approval contained an unusual quote from newly reinstated CBER director Vinay Prasad. Elsewhere, Eli Lilly and Superluminal Medicines struck a deal.
This story was originally published by ProPublica, a Pulitzer Prize-winning investigative newsroom. Sign up for The Big Story ...
Pfizer's experimental drug to treat sickle cell anemia failed to meet the main goal in a late stage trial, the drugmaker said ...
Pfizer-BioNTech has applied for full approval of its Covid-19 vaccine with the FDA. The vaccine would be the first Covid-19 vaccine approved for use in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results